Michael Egholm, Ph.D.

Michael Egholm, Ph.D.

President, Chief Executive Officer, and DirectoratStandard Biotools· In proxies 2022–2025

Pay in FY2025+6% from the year before · Standard Biotools stock -26.9% the same year

Michael Egholm, Ph.D. was paid $8.8M in FY2025 (Dec), up 6%. Standard Biotools stock fell 26.9% that year.

Pay$100 in the stock at the end of FY21 → $33
Pay is from the Summary Compensation Table of each Standard Biotools proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Standard BiotoolsPublic company · 4 yr
    • President, Chief Executive Officer, and Director2022 – Present · 4 yrStock in role -84%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?